In light of the unresolved challenges and the pressing need for an effective therapeutic strategy targeting the tumor immunosuppressive network, we have developed an intervention approach by tailoring a tumor cell‐derived GA‐targeting self‐assembled peptide (NF‐1). This evidence concerns the gene NF1 and neoplasm.